Comparison of Voglibose and Acarbose on incretin secretion and postprandial metabolic parameters in type 2 diabetes
Not Applicable
Recruiting
- Conditions
- type 2 diabetes patients
- Registration Number
- JPRN-UMIN000003142
- Lead Sponsor
- Toyama Prefectural Central Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1) Previous use of alpha-glucosidase inhibitor, DPP-4 inhibitor, GLP-1 analog within 3 months 2)Severe ketosis, diabetic coma or diabetic precoma 3)Severe hepatic dysfunction or severe kidney dysfunction 4)Severe infection or serious trauma, perioperative patients or severe injury 5)Hypersensitivity to any ingredient of Voglibose or Acarbose 6)Severe neuropathy 7)Current treatment with steroid 8)Patients judged by the investigator to be ineligible for some other reason
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method